Company news

Curatis Holding AG news in 2026

Curatis Holding AG's news releases, calls and decks from 2026, newest first.

View company

Strongest Half-Year in Curatis’s History — Revenue up 51% and Significant Progress on Corticorelin (C-PTBE-01)

September 21, 2026

Curatis Increases Revenue Growth Guidance for 2026

June 11, 2026

Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors

May 22, 2026

Curatis Holding AG announces CHF 3.0 million private placement with strategic investor

May 22, 2026

Curatis: Double-Digit Revenue Growth in 2025 and Major Milestones for Corticorelin Achieved

March 24, 2026

Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan

March 11, 2026

Decks in 2026